Allogeneic cell therapies are advancing in clinical trials, requiring oncologists and pathologists to understand the ...

FORT LEAVENWORTH, Kansas — Every three minutes, about one person is diagnosed with a form of blood cancer for which the treatment could require a bone marrow transplant with healthy bone marrow ...

What will the next decade bring for myelofibrosis care? Drs Jain and Pemmaraju explore futuristic therapies, earlier ...

New research reveals the extraordinary lengths Stone Age humans went to in order to get fat on the menu.

For over 20 years, the iQue® HTS Platform has occupied a unique position as the purpose-built cytometry solution for high-throughput screening—valued for its quality and ease of use. With the ...

Primary and secondary bone marrow–failure disorders have disparate causes, yet many of them have similar clinical presentations. The features of many of these disorders are frequently so ...